Cargando…

Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites

Objective: The study objective was to determine the reliability and validity of the Chinese version of the Functional Assessment of Chronic Illness Therapy – Ascites Index (FACIT-AI). Methods: A forward-backward translation procedure was adopted to develop the Chinese version of the FACIT-AI, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Lou, Yanni, Lu, Linghui, Li, Yuan, Liu, Meng, Bredle, Jason M., Jia, Liqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598917/
https://www.ncbi.nlm.nih.gov/pubmed/26177329
http://dx.doi.org/10.1089/jpm.2015.0061
_version_ 1782394156414402560
author Lou, Yanni
Lu, Linghui
Li, Yuan
Liu, Meng
Bredle, Jason M.
Jia, Liqun
author_facet Lou, Yanni
Lu, Linghui
Li, Yuan
Liu, Meng
Bredle, Jason M.
Jia, Liqun
author_sort Lou, Yanni
collection PubMed
description Objective: The study objective was to determine the reliability and validity of the Chinese version of the Functional Assessment of Chronic Illness Therapy – Ascites Index (FACIT-AI). Methods: A forward-backward translation procedure was adopted to develop the Chinese version of the FACIT-AI, which was tested in 69 patients with malignant ascites. Cronbach's α, split-half reliability, and test-retest reliability were used to assess the reliability of the scale. The content validity index was used to assess the content validity, while factor analysis was used for construct validity and correlation analysis was used for criterion validity. Results: The Cronbach's α was 0.772 for the total scale, and the split-half reliability was 0.693. The test-retest correlation was 0.972. The content validity index for the scale was 0.8–1.0. Four factors were extracted by factor analysis, and these contributed 63.51% of the total variance. Item-total correlations ranged from 0.591 to 0.897, and these were correlated with visual analog scale scores (correlation coefficient, 0.889; P<0.01). Conclusions: The Chinese version of the FACIT-AI has good reliability and validity and can be used as a tool to measure quality of life in Chinese patients with malignant ascites.
format Online
Article
Text
id pubmed-4598917
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Mary Ann Liebert, Inc.
record_format MEDLINE/PubMed
spelling pubmed-45989172015-10-20 Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites Lou, Yanni Lu, Linghui Li, Yuan Liu, Meng Bredle, Jason M. Jia, Liqun J Palliat Med Original Articles Objective: The study objective was to determine the reliability and validity of the Chinese version of the Functional Assessment of Chronic Illness Therapy – Ascites Index (FACIT-AI). Methods: A forward-backward translation procedure was adopted to develop the Chinese version of the FACIT-AI, which was tested in 69 patients with malignant ascites. Cronbach's α, split-half reliability, and test-retest reliability were used to assess the reliability of the scale. The content validity index was used to assess the content validity, while factor analysis was used for construct validity and correlation analysis was used for criterion validity. Results: The Cronbach's α was 0.772 for the total scale, and the split-half reliability was 0.693. The test-retest correlation was 0.972. The content validity index for the scale was 0.8–1.0. Four factors were extracted by factor analysis, and these contributed 63.51% of the total variance. Item-total correlations ranged from 0.591 to 0.897, and these were correlated with visual analog scale scores (correlation coefficient, 0.889; P<0.01). Conclusions: The Chinese version of the FACIT-AI has good reliability and validity and can be used as a tool to measure quality of life in Chinese patients with malignant ascites. Mary Ann Liebert, Inc. 2015-10-01 /pmc/articles/PMC4598917/ /pubmed/26177329 http://dx.doi.org/10.1089/jpm.2015.0061 Text en © Yanni Lou, Linghui Lu, Yuan Li, Meng Liu, Jason M. Bredle, Liqun Jia 2015; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Original Articles
Lou, Yanni
Lu, Linghui
Li, Yuan
Liu, Meng
Bredle, Jason M.
Jia, Liqun
Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites
title Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites
title_full Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites
title_fullStr Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites
title_full_unstemmed Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites
title_short Reliability and Validity of the Chinese Version of FACIT-AI, a New Tool for Assessing Quality of Life in Patients with Malignant Ascites
title_sort reliability and validity of the chinese version of facit-ai, a new tool for assessing quality of life in patients with malignant ascites
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598917/
https://www.ncbi.nlm.nih.gov/pubmed/26177329
http://dx.doi.org/10.1089/jpm.2015.0061
work_keys_str_mv AT louyanni reliabilityandvalidityofthechineseversionoffacitaianewtoolforassessingqualityoflifeinpatientswithmalignantascites
AT lulinghui reliabilityandvalidityofthechineseversionoffacitaianewtoolforassessingqualityoflifeinpatientswithmalignantascites
AT liyuan reliabilityandvalidityofthechineseversionoffacitaianewtoolforassessingqualityoflifeinpatientswithmalignantascites
AT liumeng reliabilityandvalidityofthechineseversionoffacitaianewtoolforassessingqualityoflifeinpatientswithmalignantascites
AT bredlejasonm reliabilityandvalidityofthechineseversionoffacitaianewtoolforassessingqualityoflifeinpatientswithmalignantascites
AT jialiqun reliabilityandvalidityofthechineseversionoffacitaianewtoolforassessingqualityoflifeinpatientswithmalignantascites